3 additional years of workGlaxoSmithKline Retirement Savings Plan is a defined contribution plan with a profit-sharing component, 401k feature, and ESOP component. This plan has a BrightScope Rating of 86, placing it in the top 15% of all plans in its peer group. This plan is also in the top 15% of plans for Account Balances, Company Generosity, Salary Deferral, and Total Plan Cost. GlaxoSmithKline Retirement Savings Plan currently has over 28,400 active participants and over $4.5B in plan assets.
| Address |
200 N. 16th Street
Philadelphia, PA 19102-1225 |
| Industry | Manufacturing |
| Administrator | Michelle Killian |
| Net Plan Assets | $4,500,000,000 |
| Total Participants | 28,000 |
| Avg Account Balance | $160,000 |
| Novartis Pharmaceuticals | 88.2 |
| Bayer | 87.4 |
| Bristol-Myers Squibb Company | 87.2 |
| Merck & Co. | 83.9 |
| Abbott Laboratories | 81.4 |
| Eli Lilly and Company | 79.2 |
| 1. | SSgA S&P 500 Flagship | 12% |
| 2. | GlaxoSmithKline plc Common Stock | 11% |
| 3. | American Funds EuroPacific Growth | 7% |
| Corporate Trustee | Fidelity |
| Auditor | PricewaterhouseCoopers LLP |
| Corporate Trustee | T. Rowe Price |
| Recordkeeper | ACS HR Solutions |
BrightScope Rating
Comments